Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 112 institutions that hold shares in the stock, with a total of 92.4 Million shares, which have been reported (via 13F filing form) to have a value of $135 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
119,001
shares
|
$173,741
0.0% of portfolio
|
Q1 2025
Added 682.85%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
86,348
shares
|
$126,068
0.0% of portfolio
|
Q1 2025
Reduced 66.28%
|
|
Alps Advisors Inc
Denver, CO |
Apr 30, 2025 Q1 2025 |
78,782
shares
|
$115,021
0.0% of portfolio
|
Q1 2025
Added 36.4%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
73,992
shares
|
$108,028
0.0% of portfolio
|
Q1 2025
Added 6.52%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
70,502
shares
|
$102,932
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sg Americas Securities, LLC
|
Apr 15, 2025 Q1 2025 |
67,933
shares
|
$99,182
0.0% of portfolio
|
Q1 2025
New holding
|
|
Jain Global LLC
New York, NY |
May 15, 2025 Q1 2025 |
65,672
shares
|
$95,881
0.0% of portfolio
|
Q1 2025
Added 168.49%
|
|
Exodus Point Capital Management, LP
New York, NY |
May 14, 2025 Q1 2025 |
59,865
shares
|
$87,402
0.0% of portfolio
|
Q1 2025
Added 462.8%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
57,079
shares
|
$83,335
0.0% of portfolio
|
Q1 2025
Added 408.95%
|
|
Boothbay Fund Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
53,478
shares
|
$78,077
0.0% of portfolio
|
Q1 2025
Reduced 52.46%
|
|
Quantessence Capital LLC
New York, NY |
May 15, 2025 Q1 2025 |
51,664
shares
|
$75,429
0.02% of portfolio
|
Q1 2025
New holding
|
|
Lmr Partners LLP
London, X0 |
May 15, 2025 Q1 2025 |
48,360
shares
|
$70,605
0.0% of portfolio
|
Q1 2025
New holding
|
|
State Of Wyoming
Cheyenne, WY |
May 14, 2025 Q1 2025 |
46,861
shares
|
$68,417
0.01% of portfolio
|
Q1 2025
New holding
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
May 15, 2025 Q1 2025 |
45,659
shares
|
$66,662
0.02% of portfolio
|
Q1 2025
Reduced 5.25%
|
|
Cambridge Investment Research Advisors, Inc.
|
Apr 22, 2025 Q1 2025 |
41,873
shares
|
$61,134
0.0% of portfolio
|
Q4 2023
Added 173.0%
|
|
Engineers Gate Manager LP
New York, NY |
May 15, 2025 Q1 2025 |
40,242
shares
|
$58,753
0.0% of portfolio
|
Q1 2025
Reduced 56.98%
|
|
Jefferies Financial Group Inc.
New York, NY |
May 08, 2025 Q1 2025 |
40,200
shares
|
$58,692
0.0% of portfolio
|
Q1 2025
Reduced 1.23%
|
|
Algert Global LLC
San Francisco, CA |
May 13, 2025 Q1 2025 |
39,850
shares
|
$58,181
0.0% of portfolio
|
Q1 2025
New holding
|
|
Quadrature Capital LTD
London, X0 |
May 13, 2025 Q1 2025 |
39,331
shares
|
$57,423
0.0% of portfolio
|
Q1 2025
New holding
|
|
Mariner, LLC
Overland Park, KS |
May 15, 2025 Q1 2025 |
37,969
shares
|
$55,434
0.0% of portfolio
|
Q1 2025
Added 0.52%
|
|
Cannon Global Investment Management, LLC
|
Apr 28, 2025 Q1 2025 |
37,400
shares
|
$54,604
0.11% of portfolio
|
Q1 2025
New holding
|
|
Verition Fund Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
35,805
shares
|
$52,275
0.0% of portfolio
|
Q1 2025
New holding
|
|
Velan Capital Investment Management LP
Alpharetta, GA |
May 15, 2025 Q1 2025 |
35,000
shares
|
$51,100
0.09% of portfolio
|
Q1 2025
Added 29.63%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
33,079
shares
|
$48,295
0.0% of portfolio
|
Q4 2024
New holding
|
|
Gsa Capital Partners LLP
London, X0 |
May 08, 2025 Q1 2025 |
30,516
shares
|
$44,553
0.0% of portfolio
|
Q1 2025
New holding
|